Novo Nordisk Expansion in Clayton, NC
Novo Nordisk plans $2 Billion investment in new production facilities in Clayton, North Carolina and Måløv, Denmark
Our company will invest approximately $1.8 billion at the Clayton site over the next five years. This expansion will create approximately 700 new jobs and contribute local and state economies.
Mar 28, 2016
Novo Nordisk breaks ground on nearly $2 billion diabetes medicine production facility in Clayton, North Carolina
Production expansion to bring 700 jobs to Clayton